(Q33215101)

English

Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

author name string

Kissel T

1

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Drewe J

2

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Bantle S

3

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Rummelt A

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Beglinger C

5

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Pharmaceutical Research

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

52-57

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Somatostatin and its analogues in the therapy of gastrointestinal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide, a new somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of sandostatin, a new synthetic somatostatin analogue, in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of absorption enhancers on human nasal tissue ciliary movement in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Transnasal administration of drugs. 2. Models for studying nasal absorption in animals and parameters susceptible to influence]

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of bile salts on nasal permeability in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of surface-active agents in drug absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All aboard for octreotide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal absorption of insulin: enhancement by hydrophobic bile salts

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of SMS 201-995 in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic criteria for the evaluation of retard formulations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1018927710280

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33215101&oldid=1633833959"